Use of monoclonal antibodies in vivo as a therapeutic strategy for alloimmune or autoimmune reactivity: the Besançon experience (Q35595930)
Jump to navigation
Jump to search
scientific article published on October 1, 1992
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Use of monoclonal antibodies in vivo as a therapeutic strategy for alloimmune or autoimmune reactivity: the Besançon experience |
scientific article published on October 1, 1992 |
Statements
1 reference
Use of monoclonal antibodies in vivo as a therapeutic strategy for alloimmune or autoimmune reactivity: the Besançon experience (English)
1 reference
P. Herve
E. Racadot
D. Wendling
L. Rumbach
P. Tiberghien
J. Y. Cahn
M. Flesch
1 October 1992
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference